Namwiwat Medical Corporation Public Company Limited Proposes Dividend for the Year 2023, Payable Within Date on ... - Marketscreener.com
| NAM Stock | 4.70 0.02 0.42% |
About 61% of Namwiwat Medical's investor base is looking to short. The analysis of current outlook of investing in Namwiwat Medical suggests that many traders are alarmed regarding Namwiwat Medical's prospects. Namwiwat Medical's investing sentiment shows overall attitude of investors towards Namwiwat Medical.
Namwiwat |
Namwiwat Medical Corporation Public Company Limited Proposes Dividend for the Year 2023, Payable Within Date on ... Marketscreener.com
Read at news.google.com
 |
Namwiwat Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Namwiwat Medical stock to make a market-neutral strategy. Peer analysis of Namwiwat Medical could also be used in its relative valuation, which is a method of valuing Namwiwat Medical by comparing valuation metrics with similar companies.
Peers
Namwiwat Medical Related Equities
| NSL | NSL Foods | 1.67 | ||||
| HANA | Hana Microelectronics | 0.98 | ||||
| HFT | Hwa Fong | 0.97 | ||||
| CPF-R | Charoen Pokphand | 0.42 | ||||
| DIF | Digital Telecommunicatio | 0.56 | ||||
| RBF | RB Food | 3.03 | ||||
| NV | Nova Organic | 3.06 |